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A B S T R A C T
Background: Although same-day discharge (SDD) after elective uncomplicated percutaneous coronary 
intervention (PCI) be adopted worldwide, it remains poorly studied in our country. We aim to evaluate our 
initial experience with SDD after elective PCI, regarding its safety and predictors of success.
Methods: A hundred and sixty-one single-center consecutive patients, selected in a specialized outpatient 
clinic, were included for SDD. To identify the factors associated with SDD, single and multiple logistic 
regression models were adjusted.
Results: SDD was successfully performed in 114 patients (70.8%) and the remaining 47 patients remained 
hospitalized (45 with discharge in the following morning and 2 patients after 2 days). No patient with 
SDD presented major adverse cardiac events or major vascular complications at 30 days or at a median 
follow-up of 12 months. In the inpatient group, there was only one case of acute myocardial infarction due 
to a lateral branch occlusion and two patients with > 5 cm hematoma related to the access site. The SDD 
predictors were radial access route (OR = 5.92; 95%CI 1.73-20.21; p = 0.005), presence of type A/B1 lesions 
(OR = 14.09; 95%CI 1.70-116.49%; p = 0.01) and contrast volume (OR = 0.76; 95%CI 0.65-0.88; p < 0.001).
Conclusions: SDD was safe and could be successfully performed in most patients selected for elective PCI, 
and its predictors were the radial access, less complex coronary lesions and a and lower contrast volume.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Published by Elsevier Editora Ltda. 
This is an open access article under the CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
 
Segurança e preditores de sucesso da alta hospitalar no mesmo dia após 
intervenção coronária percutânea eletiva
R E S U M O
Introdução: Apesar de a alta hospitalar no mesmo dia (AHMD) após intervenção coronária percutânea 
(ICP) eletiva não complicada ser adotada mundialmente, ela permanece pouco estudada em nosso meio. 
Objetivamos, assim, avaliar nossa experiência inicial com a AHMD após ICP eletiva, em relação à sua 
segurança e aos preditores de sucesso.
Métodos: Foram incluídos 161 pacientes consecutivos para AHMD, de único centro, selecionados em 
ambulatório especializado. Para a identificação dos fatores associados ao sucesso da AHMD, foram 
ajustados modelos de regressão logística simples e múltipla.
Resultados: A AHMD foi realizada com sucesso em 114 pacientes (70,8%), tendo os 47 pacientes restantes 
permanecido internados (45 com alta na manhã seguinte e 2 pacientes após 2 dias). Nenhum paciente 
com AHMD apresentou evento cardíaco adverso maior ou complicação vascular importante aos 30 dias 
e no seguimento mediano de 12 meses. No grupo internação, ocorreu apenas um caso de infarto agudo 
do miocárdio por oclusão de ramo lateral e dois hematomas > 5 cm relacionados ao sítio de punção. 
Os preditores de sucesso da AHMD foram: via de acesso radial (OR = 5,92; IC95% 1,73-20,21; p = 0,005), 
presença de lesões tipo A/B1 (OR = 14,09; IC95% 1,70-116,49; p = 0,014) e volume de contraste (OR = 0,76; 
IC95% 0,65-0,88; p < 0,001).
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Introduction
Since it was first performed more than three decades ago, percu-
taneous coronary intervention (PCI) has become the most widely 
used method for coronary revascularization worldwide. Technique 
improvement, together with the technological advancement of 
dedicated materials and effectiveness of adjunctive medication, 
greatly improved procedure safety and success, reducing complica-
tions and resulting in shorter hospital stay.1-5
These technological advances, however, allowed for the in-
creasing number of PCIs and led to greater costs, resulting in hos-
pital management policies directed at cost reduction logistics, 
while preserving clinical efficacy, safety, and patient satisfaction 
with the procedure.6-9 In this sense, previous studies have shown a 
significant reduction in PCI-related costs, including selected elec-
tive patients with low risk of complications in a same-day hospital 
discharge (SDD) program.10 The concept of SDD has been evaluated 
in several studies, which were grouped in a recent meta-analysis 
that confirmed the safety and efficacy of SDD in comparison with 
overnight in-hospital observation for uncomplicated elective 
PCIs.11,12
SDD in uncomplicated PCIs, although well established in the 
practice of global interventional cardiology,11 remains little studied 
and used in Brazil.13 Additionally, there are few data in the literature 
about predictors of success in the implementation of such practice. 
In this sense, the aims of this study were to evaluate an initial expe-
rience with SDD after elective PCI regarding its safety and predictors 
of success.
Methods
Study population
Consecutive patients referred for elective angioplasty between 
March 2013 and November 2014 (n = 459), from a single center, were 
evaluated as outpatients by an interventional cardiologist from this 
service (F.C.) before PCI. The study was approved by the Research 
Ethics Committee of the institution and all patients signed an in-
formed consent prior to the procedure.
Based on the appropriateness criteria for PCI performance14 and 
previous SDD studies,2,7,11,12,15,16 the following criteria were applied, 
with the intention of selecting patients eligible for the study: (1) 
presence of stable angina, crescendo angina or asymptomatic pa-
tients with positive functional test for ischemia; (2) elective angio-
plasty of one or two vessels; (3) absence of significant medical 
comorbidities that would justify the need for a longer hospital stay 
to prepare the patient for the procedure and post-angioplasty care, 
such as heart failure and ejection fraction < 35%, chronic renal fail-
ure (creatinine clearance < 60 mL/min), hemorrhagic diathesis or 
known bleeding disorders, symptomatic chronic obstructive pulmo-
nary disease, allergy to contrast, frailty and/or age > 80 years; (4) 
low- or intermediate-complexity coronary anatomy (SYNTAX score 
< 33) that did not involve the left main coronary artery or lesions in 
bifurcations scheduled to be treated with two stents; (5) possibility 
to perform the procedure through radial access, or via the femoral 
access, preferably with a 5F sheath.
After the procedure, the following criteria were considered for 
SDD: no complications during PCI; absence of prolonged chest pain 
during the procedure or chest pain in the recovery period post-PCI; 
no elevation in myocardial necrosis markers 6 hours after the proce-
dure or new electrocardiographic alteration suggesting ischemia; 
absence of vascular complications or hematoma > 5 cm related to the 
puncture site; PCIs preferably performed in the morning, due to the 
recovery time considering the vascular access.
Procedure
For patients eligible for SDD, the antiplatelet agent used was 
clopidogrel 300 mg as loading dose, administered 24 hours before 
the procedure (with an additional dose of 300 mg immediately af-
ter the PCI), followed by 75 mg/day for at least 30 days for bare-
metal stents or one year for drug-eluting stents. For patients that 
were already using clopidogrel, an additional dose of 300 mg was 
administered at the end of the procedure. For those receiving ti-
cagrelor or prasugrel, 90 and 10 mg were administered at the end of 
the procedure, respectively. Additionally, patients were prescribed 
acetylsalicylic acid (100 mg per day) indefinitely. The transradial 
approach was the most commonly used, with the transfemoral 
approach used as an alternative when it was impossible to use the 
transradial approach or when it failed. After obtaining vascular 
access (5F or 6F sheath), unfractionated heparin was administered 
at a dose of 100 IU/kg. Glycoprotein IIb/IIIa inhibitors were not 
used. The procedure followed the currently established technique, 
using direct stenting whenever possible. After the PCI, the sheaths 
were immediately removed. For the transfemoral approach, a prot-
amine dose was administered (1 mL of Protamine 1000TM to neu-
tralize 1,000 IU of heparin) and the sheath was removed with 
manual compression for 15 to 30 minutes, followed by compressive 
dressing and limb rest for at least four hours. In the case of transra-
dial approach, a hemostatic strap (TR BandTM; Terumo Medical Co., 
Elkton, USA) was used, followed by limb rest for 2 hours. Post-pro-
cedure control included an electrocardiogram (compared to an 
electrocardiogram performed prior to PCI), vital signs, and physical 
examination of the access route. High-sensitivity troponin mea-
surement was performed 6 hours after the procedure in all patients 
eligible for SDD. Patients that remained asymptomatic without 
electrocardiographic alterations or significant increase in troponin 
levels and no complications at the puncture site were discharged, 
with recommendations on medication, additional rest periods, pos-
sible complications, and outpatient return visit for reassessment. In 
case of any signs or symptoms related to the procedure, they were 
advised to seek the emergency service of this hospital.
Data collection and analysis
The study data collection was performed by nurses and doctors 
trained during the index hospitalization, following the completion 
of previously standardized forms. Data collection included clinical 
characteristics, laboratory test results, data on the invasive proce-
Conclusões: A AHMD foi segura e pôde ser realizada com sucesso na maioria dos pacientes selecionados 
para ICP eletiva, sendo seus preditores de sucesso o acesso radial, as lesões menos complexas e um volume 
menor de contraste.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Publicado por Elsevier Editora Ltda. 
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dure, and clinical outcome until hospital discharge. After discharge, 
clinical follow-up of patients was performed on an outpatient basis 
within 30 days of the procedure and, thereafter, by telephone con-
tact and review of hospital records.
All angiograms were analyzed by the Hemodynamics and Inter-
ventional Cardiology Service of the hospital where the study was 
conducted to determine procedure success, vessel measurements 
and characteristics, as well as angiographic adverse events (F.C. and 
H.B.R.). Image acquisition was performed using two or more angio-
graphic projections of the stenosis after nitrate administration. 
These projections were repeated at the time of the follow-up angi-
ography in cases where necessary. Qualitative morphological 
characteristics were assessed using standardized criteria.17,18
Outcomes and definitions
The primary safety outcome was the occurrence of major adverse 
cardiac events (death, acute myocardial infarction – AMI) and rein-
tervention, as well as stent thrombosis rate, hospital readmission, 
and vascular complications at 30 days. These outcomes were also 
evaluated in the late follow-up period of 12 months, as well as pre-
dictors of SDD, based on clinical and angiographic characteristics 
and in-hospital outcomes.
The deaths included cardiac and non-cardiac causes. The diagno-
sis of AMI with ST-segment elevation, stable angina, and unstable 
angina followed previously described criteria.17,18 Increase in 
markers > 5 times the upper limit of normality (ULN of troponin of 
0.01 μg/L) was considered a significant troponin elevation.19 Angiog-
raphic success was defined as achieving a target lesion < 30%, while 
maintaining or restoring the normal antegrade flow (Thrombolysis 
In Myocardial Infarction –TIMI 3). Target-lesion revascularization 
was defined as a new intervention, surgical or percutaneous, in le-
sions > 50% within the previously implanted stent or in the segment 
that included the 5 mm proximal and/or 5 mm distal to the stent. 
Stent thrombosis was defined according to the classification of the 
Academic Research Consortium.20
Intra-procedure complications included prolonged chest pain, 
hemodynamic instability, transient vessel occlusion, no-reflow and 
slow-flow phenomenon, side branch occlusion > 1.5 mm, and subop-
timal angiographic result. The lesions were classified into types A, 
B1, B2 and C, according to the American College of Cardiology/Amer-
ican Heart Association (ACC/AHA).21 Vascular complications included 
major bleeding according to TIMI classification (intracranial hemor-
rhage or decrease > 5 mg/dL of hemoglobin or 15% of hematocrit), 
significant hematoma at the puncture site > 5 cm, pseudoaneurysm, 
fistula, or thrombosis requiring surgical intervention.15
Statistical analysis
Categorical variables were expressed as frequencies and percent-
ages, and compared with the Chi-squared test. Continuous variables 
were described as mean and standard deviations, or median and in-
terquartile range (25th and 75th percentiles), and were compared 
with Student’s t-test or analysis of variance (ANOVA). Univariate and 
multivariate models using binary logistic regression were used to 
identify predictors of SDD success, with the variables showing a 
value of p < 0.05 included in the multivariate model. All tests were 
two-tailed and a p-value of < 0.05 was considered statistically sig-
nificant. Analyses were performed using SPSS version 20.0 (SPSS 
Inc., Chicago, USA).
Results
During the study period, 161 patients were selected for SDD, and 
this strategy was adopted successfully in 114 patients (70.8%); the 
remaining 47 patients (29.2%) remained hospitalized (45 discharged 
in the following morning and 2 patients after two days). Clinical 
characteristics of the overall study population, as well as in relation 
to SDD groups and hospitalization, are shown in Table 1. Both groups 
were very similar, with a majority of male patients, mean age of 61 ± 
11 years, and high prevalence of diabetes (42.9%). Most patients had 
stable angina (73.9%) and preserved left ventricular ejection fraction 
(61% ± 9% vs. 62% ± 6%, p = 0.56).
Angiographic characteristics are shown in Table 2. Transradial 
access and 6F sheath were more often used in the SDD group (91.2% 
vs. 72.3%; p = 0.002; and 84.2% vs. 57.4%; p < 0.001, respectively). Al-
though both groups had similar arterial patterns, the complexity of 
the interventions was lower in the SDD group when compared to the 
hospital admission group. This was demonstrated by the lower num-
ber of lesions treated per patient (1.25 ± 0.47 vs. 1.47 ± 0.58; p = 0.01), 
the lower complexity of lesions (B2/C type lesions 66.7% vs. 97.9%; 
p < 0.01), and the lower number of stents/patient (1.25 ± 0.51 vs. 1.79 
± 0.88; p < 0.001).
Hospital outcomes are shown in Table 3. Regarding access route 
complications, hematomas > 5 cm were observed in 2 patients from 
the hospital group in the first 12 hours after the intervention, and 
small hematomas (< 5 cm) in 11 patients, 9 in the SDD group and 2 
the hospital admission group (p = 0.51). There were no cases of pseu-
doaneurysm or arteriovenous fistula in either group. Increased tro-
ponin > 5 times the ULN, although an exclusion criterion for SDD, 
occurred in 2.6% of cases in this group. Regarding major adverse car-
diac complications, there was only 1 case of AMI in the hospitaliza-
tion group due to side branch occlusion, associated with chest pain, 
electrocardiographic alterations, and elevation of myocardial necro-
sis markers. There were no deaths or reinterventions in either group 
up to a median follow-up period of 12 months (6.2 to 28.7 months).
The main reasons for SDD failure in this population are shown 
in the Figure 1. Independent predictors of SDD success at the 
multivariate analysis are shown in Table 4. Transradial access (OR 
= 5.920; 95%CI 1.73-20.21; p = 0.005), the presence of A/B1 lesions 
(OR = 14.09; 95%CI 1.70-116.49; p = 0.01), and contrast volume (OR 
= 0.76; 95%CI 0.65-0.88; p < 0.001) were factors related to SDD.
Table 1
Basal clinical characteristics.
Total  
(n = 161)
SDD  
(n = 114)
Hospital 
admission 
(n = 47) p-value
Age, years 61 ± 11 61 ± 11 61 ± 11 0.72
Male gender, n (%) 132 (82.0) 94 (82.5) 38 (80.9) 0.81
Diabetes mellitus, n (%) 69 (42.9) 49 (43.0) 20 (42.6) 0.96
Using insulin 23 (33.3) 16 (32.7) 7 (35.0) 0.89
Arterial hypertension, n (%) 136 (84.5) 97 (85.1) 39 (83.0) 0.74
Dyslipidemia, n (%) 139 (86.3) 102 (89.5) 37 (78.7) 0.07
Current smoking, n (%) 21 (13.0) 16 (14.0) 5 (10.6) 0.56
Peripheral vascular disease, n (%) 2 (1.2) 2 (1.8) 0 (0) > 0.99
Previous PCI, n (%) 25 (15.5) 18 (15.8) 7 (14.9) 0.89
Previous CABG, n (%) 23 (14.3) 18 (15.8) 5 (10.6) 0.40
Chronic renal failure, n (%) 10 (6.2) 8 (7.0) 1 (2.1) 0.14
Creatinine clearance, mL/min 85.8 ± 20.0 85.3 ± 21.5 86.9 ± 16.3 0.68
LVEF, % 61 ± 8 61 ± 9 62 ± 6 0.56
Clinical picture, n (%) 0.14
Stable angina 11 (73.9) 80 (70.2) 39 (83.0)
Asymptomatic 29 (18.0) 22 (19.3) 7 (14.9)
Ischemic equivalent 13 (8.1) 12 (10.5) 1 (2.1)
Non-invasive test, n (%) 127 (78.9) 98 (86.0) 29 (61.7) 0.001
Exercise test 27 (16.8) 21 (18.4) 6 (12.8) 0.38
Myocardial scintigraphy 96 (59.6) 71 (62.3) 25 (53.2) 0.29
Stress echocardiography 6 (3.7) 6 (5.3) 0 (0) 0.11
Angiotomography 10 (6.2) 6 (5.3) 4 (8.5) 0.44
Myocardial Resonance 1 (0.6) 1 (0.9) 0 (0) 0.52
SDD: same-day discharge; PCI: percutaneous coronary intervention; CABG: coronary artery bypass 
graft surgery; LVEF: left ventricular ejection fraction.
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Discussion
The present study aimed to evaluate an initial experience with 
SDD after elective PCI regarding its safety, as well as predictors of 
success. In a consecutive population of 161 pre-PCI patients selected 
from the outpatient clinic, SDD was successfully applied to the ma-
jority of patients (71%), and the rate of major adverse cardiac event 
was low in both groups (SDD and hospital admission), while no 
events were observed in the patients from the SDD group. SDD 
success predictors were the use of transradial access, less complex 
angiographic lesions, and lower volume of contrast used.
Since the first reports of success almost two decades ago,22 SDD 
practice has faced a number of barriers for its implementation as a 
viable strategy in elective patients undergoing PCI. The concerns 
included forensic safety issues, patient preference and satisfaction, 
and cost analysis.23-27 Nevertheless, several studies over the last few 
years have evaluated the practice of SDD, with quite interesting 
results. These results were grouped into an important meta-analysis 
by Abdelaal et al.,11 involving five randomized and eight observa-
tional trials, with a total of 111,830 patients included. Although 
different methods of SDD practice have been observed among the 
assessed studies, its broad applicability was demonstrated, with low 
rates of cardiovascular adverse events, repeated hospitalizations, 
and overall complications, confirming it as a viable alternative in un-
complicated elective PCIs.
The experience with SDD is small in Brazil.13 In the present study, 
which evaluated consecutive patients selected for SDD, it was 
possible in 71%, whereas 29% were hospitalized and discharged on 
the following day. This is somewhat higher than the rate of 10%-20% 
observed in the literature.15 When analyzing the main reasons that 
led patients to not have SDD, vascular access (femoral) and proce-
dure complexity were the most important. Most SDD studies as-
sessed the safety and efficacy of this strategy using the transradial 
approach, in order to minimize possible vascular access complica-
tions. In the present study, 85.7% of the patients were treated with 
the transradial approach and 14.3%, the transfemoral, with the latter 
increasing the chance of hospitalization by six-fold, although a 
smaller-caliber sheath (5 F) was used in most cases. Because of the 
Table 2
Angiographic characteristics.
Total  
(n = 161)
SDD 
(n = 114)
Hospital 
admission  
(n = 47) p-value
Access route, n (%) 0.002
Radial 138 (85.7) 104 (91.2) 34 (72.3)
Femoral 23 (14.3) 10 (8.8) 13 (27.7)
Sheath caliber, n (%) < 0.001
5 F 38 (23.6) 18 (15.8) 20 (42.6)
6 F 123 (76.4) 96 (84.2) 27 (57.4)
Lesions treated per patient 1.31 ± 0.52 1.25 ± 0.47 1.47 ± 0.58 0.01
Vessels treated per patient 1.22 ± 0.43 1.18 ± 0.38 1.32 ± 0.52 0.05
Stents per patient 1.40 ± 0.68 1.25 ± 0.51 1.79 ± 0.88 < 0.001
Two or more lesions, n (%) 85 (52.8) 55 (48.2) 30 (63.8) 0.07
Arterial pattern, n (%) 0.41
One-vessel 66 (41.0) 49 (43.0) 17 (36.2)
Two-vessel 61 (37.9) 44 (38.6) 17 (36.2)
Three-vessel 34 (21.1) 21 (18.4) 13 (27.7)
Approached territory, n (%) 0.04
LAD 57 (35.4) 42 (36.8) 15 (31.9)
LCx 35 (21.7) 29 (25.4) 6 (12.8)
RCA 48 (29.8) 33 (28.9) 15 (31.9)
Two or more territories, n (%) 21 (13.0) 10 (8.8) 11 (23.4) 0.02
B2/C lesions, n (%) 122 (75.8) 76 (66.7) 46 (97.9) < 0.001
Total stent length, mm 30 ± 16 27 ± 13 39 ± 17 < 0.001
Type of device, n (%) 0.001
Bare-metal stent 45 (28.0) 39 (34.2) 6 (12.8)
Drug-eluting stent 99 (61.5) 68 (59.6) 31 (66.0)
Both 14 (8.7) 7 (6.1) 7 (14.9)
Drug-eluting balloon 3 (1.9) 0 (0) 3 (6.4)
Contrast volume, mL 109 (39) 97 ± 35 138 ± 31 < 0.001
SDD: same-day discharge; LAD: left anterior descending artery; LCx: left circumflex artery; 
RCA: right coronary artery.
Table 3
In-hospital outcomes.
Total  
(n = 161)
SDD  
(n = 114)
Hospital 
admission  
(n = 47) p-value
Access complications, n (%)
Hematoma, n (%)
> 5 cm 2 (1.2) 0 (0) 2 (4.3) 0.08
≤ 5 cm 11 (6.8) 9 (7.9) 2 (4.3) 0.51
Arteriovenous fistula or 
pseudoaneurysm
0 (0) 0 (0) 0 (0) NA
MACE, n (%)
Death 0 (0) 0 (0) 0 (0) NA
Reintervention 0 (0) 0 (0) 0 (0) NA
Myocardial infarction 1 (0.6) 0 (0) 1 (2.1) 0.29
Increase > 5-fold in troponin, n (%) 13 (8.1) 3 (2.6) 10 (21.3) < 0.001
SDD: same-day discharge; MACE: major adverse cardiac events; NA: not applicable.
Figure 1. Main reasons for same-day hospital discharge failure. * Complex procedure 
was defined as one involving ≥ 2 lesions or ≥ 150 mL of contrast or ≥ 45 minutes of 
procedure. DAPT: dual antiplatelet therapy; PCI: percutaneous coronary intervention.
Table 4
Same-day hospital discharge success predictors.
Univariate 
analysis  
OR (95%CI) p-value
Multivariate 
analysis  
OR (95%CI) p-value
Radial access 3.98 (1.60-9.89) 0.003 5.92 (1.73-20.21) 0.005
A/B1 lesions (AHA/ACC) 23.0 (3.05-173.22) 0.002 14.09 (1.70-116.49) 0.01
Number of treated 
lesions  
0.45 (0.24-0.86) 0.015 1.62 (0.69-3.78) 0.27
Contrast volume* 0.71 (0.63-0.81) < 0.001 0.76 (0.65-0.88) < 0.001
Troponin at discharge 0.20 (0.07-0.55) 0.002 0.49 (0.15-1.60) 0.24
OR: odds ratio; 95%CI: 95% confidence interval; AHA/ACC: American Heart Association/American 
College of Cardiology.
* For each increment of 10 mL of contrast volume.
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shorter recovery time and clear benefits regarding vascular compli-
cation reduction, the transradial approach should be preferred when 
using SDD.11,16,28 However, the femoral approach is still widely used 
globally, especially in European countries, the USA, and many states 
of Brazil. Thus, early discharge with the transfemoral approach has 
been described with good safety in some studies and can also be 
used.12,29
The present study showed high safety regarding hospital out-
comes 30 days after the procedure and at late follow-up, as 
previously demonstrated in the literature.11,16,30,31 There were only 
two cases of major vascular complications (hematoma > 5 cm at the 
vascular access site) observed within 6 hours after PCI and only one 
case of symptomatic AMI due to side branch occlusion during the 
procedure. There were no cases of death or reintervention at a me-
dian follow-up of 12 months. Additionally, among patients with 
significant troponin increase (8.1%), no clinical implication was ob-
served related to the isolated elevation of these markers, with three 
of these patients receiving SDD and ten hospitalized for overnight 
observation. Heyde et al.,12 in a previous randomized trial, also ob-
served low rate of adverse clinical events, none of which occurred 
between 6 and 24 hours after the procedure, validating the reliabil-
ity of the SDD monitoring only in the first 6 hours. In Brazil, Trindade 
et al.,13 retrospectively evaluating 69 patients included in a SDD pro-
tocol, also demonstrated its safety after a mean observation period 
of 6.8 hours; no clinical events were identified during a 30-day fol-
low-up.
Building a successful SDD program requires the choice and 
involvement of a multidisciplinary team, as well as all health care 
professionals involved in patient care. The selection of these patients 
involves institutional re-education, naturally focused on a well-
established program of pre-procedure screening, strengthening the 
doctor-patient-family relationship, with contingency planning for 
likely emergencies and thorough monitoring in the short and long 
term after the procedure. Considering this strategy, the pre-angio-
plasty assessment clinic was implemented in this hospital so that an 
interventional cardiologist could select the ideal candidates for the 
implementation of the SDD project. This patient selection showed, in 
the literature, to be capable of reducing post-PCI complications such 
as ischemic events (abrupt occlusion of major vessels and secondary 
branches, and dissections of borders), periprocedural infarction, and 
acute stent thrombosis, as well as reducing bleeding and vascular 
complications.28,32
Limitations
This was a single-center study with a small sample and selected 
patients and, thus, potential selection biases may have influenced 
the results and its generalization to other centers with different 
characteristics may not be possible. In the present study, the degree 
of satisfaction was not assessed; it should be the subject of future 
studies. Hospital costs, as well as their potential reduction with SDD, 
were not specifically assessed in this study, and this should also be 
considered in future studies.
Conclusions
In patients selected from an outpatient clinic, with low risk for 
PCI, the SDD strategy was achieved in most cases and was safe in 
this Brazilian hospital, regarding rates of major adverse cardiac 
events and vascular complications. Predictors of success were use of 
transradial access and less complex angiographic lesions – noting 
that the transradial access should be preferred and that patient 
selection is crucial. The increasing number of elective PCI proce-
dures and the costs involved with this increase over the years make 
SDD a worthwhile logistics strategy to reduce hospital costs. In this 
sense, the results of the present study, consistent with several stud-
ies in the literature, indicate that SDD should be encouraged for low-
risk patients undergoing elective PCI in Brazil.
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